Patient materials

Access materials to support your haemophilia patients.

View materials

Pfizer and Haemophilia

Pfizer's journey with Haemophilia
Click here to learn about Pfizer's journey with Haemophilia

Contact Pfizer

Speak to a member of the Pfizer Haemophilia team by using the form below.

Contact a member of the Pfizer Haemophilia Team

BeneFIX®

Click here to visit the BeneFIX homepage

Click here for the BeneFIX homepage

ReFacto AF®

Click here to visit the ReFacto homepage

Click here for the ReFacto AF homepage

What is haemophilia?

Haemophilia is a lifelong condition requiring constant and careful management. The most common forms of haemophillia are caused by deficiency in a particular coagulation factor – factor VIII (FVIII) in haemophilia A and factor IX (FIX) in haemophilia B.

Haemophilia is quite rare; about 1 in 10,000 people are born with it1.

Treatment of haemophilia

A primary aim of care in haemophilia is to prevent and treat bleeding with the deficient clotting factor2:

  • On-demand: Treatment given at the time of clinically evident bleeding
  • Prophylaxis: Treatment given in order to prevent anticipated bleeding


References: 1. World Federation of Hemophilia. What is Hemophilia? Available at: http://www1.wfh.org/publications/files/pdf-1324.pdf (accessed April 2019). 2.World Federation of Hemophilia. Guidelines for the Management of Hemophilia–2nd Edition. Available at: http://www1.wfh.org/publications/files/pdf-1472.pdf (accessed April 2019). 

PP-BEN-GBR-0264, April 2019

Click here for BeneFIX® prescribing information.
Click here for ReFacto AF® prescribing information.